Search for: "Mylan Pharmaceuticals"
Results 1 - 20
of 738
Sort by Relevance
|
Sort by Date
24 Apr 2024, 4:52 am
For example, Mylan and Mallinckrodt settled significant cases alleging Medicaid rebate fraud brought by our whistleblower clients. [read post]
9 Apr 2024, 2:56 pm
Intellectual property (“IP”) development can cost millions of dollars so cost recovery timing can be financially material. [read post]
1 Apr 2024, 10:58 am
Overall, this is a bad case for pharmaceutical formulary patents. [read post]
13 Mar 2024, 7:24 pm
§ 1.750, applicant is required to submit the following to the Office: Evidence that Opko Biologics Ltd. is expressly authorized to rely upon the regulatory review activities by Pfizer Ireland Pharmaceuticals (Pfizer), the marketing applicant before the Food and Drug Administration to support the application for patent term extension of U.S. [read post]
9 Feb 2024, 11:08 am
” Similarly, as show in the Mylan Laby’s, Inc. v. [read post]
15 Jan 2024, 3:16 am
Mylan then filed a complaint against Gilead claiming the damages allegedly caused by the preliminary injunction. [read post]
14 Jan 2024, 9:29 pm
Mylan Pharmaceuticals Inc. [read post]
2 Jan 2024, 8:45 pm
Mylan Pharmaceuticals Inc. [read post]
19 Dec 2023, 7:40 am
It should be noted that Judge Sabotier, author of two of the Court’s orders (NOVARTIS vs MYLAN of August 4, 2022, and SHARK ROBOTICS of November 7, 2022), now sits on the Cour de Cassation bench. [read post]
18 Dec 2023, 9:07 pm
Mylan Pharmaceuticals Inc. [read post]
13 Dec 2023, 8:25 pm
Mylan Pharmaceuticals Inc. [read post]
7 Dec 2023, 9:59 pm
Mylan Pharmaceuticals Inc., with the Court vacating and remanding the District Court's claim construction for failure to consider extrinsic evidence. [read post]
6 Nov 2023, 1:15 pm
Mylan Pharmaceuticals Inc. vacating an infringement judgment against Mylan in the Northern District of West Virginia. [read post]
6 Nov 2023, 1:15 pm
Mylan Pharmaceuticals Inc. vacating an infringement judgment against Mylan in the Northern District of West Virginia. [read post]
6 Nov 2023, 8:35 am
Mylan Pharmaceuticals Inc., No. 2022-1889 (Fed. [read post]
17 Oct 2023, 3:40 pm
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eig [read post]
6 Oct 2023, 10:45 am
Court of Appeals for the Federal Circuit (CAFC) issues two precedential patent opinions; X Social Media sues Elon Musk’s social media platform X for copyright infringement; and the PTAB grants Mylan Pharmaceutical’s petition for an inter partes review on the validity of Novo Nordisk’s Ozempic and Wegovy patents. [read post]
6 Oct 2023, 10:45 am
Court of Appeals for the Federal Circuit (CAFC) issues two precedential patent opinions; X Social Media sues Elon Musk’s social media platform X for copyright infringement; and the PTAB grants Mylan Pharmaceutical’s petition for an inter partes review on the validity of Novo Nordisk’s Ozempic and Wegovy patents. [read post]
24 Aug 2023, 9:41 am
NovartisNovartis owned a European patent (EP 0 948 320) relating to pharmaceutical compositions for sustained release of the HMG-CoA reductase inhibitor Fluvastatin. [read post]
2 Aug 2023, 11:05 am
Sanofi argued on appeal that the Board erroneously agreed with Mylan’s argument that de Gennes constituted analogous art because Mylan incorrectly compared the de Gennes reference to another prior art reference, and not the ’614 patent. [read post]
